화이자(Pfizer)의 항암제(Oncology) 분야에서 암 환자의 삶을 개선할 혁신적인 치료제 개발에 참여할 인재를 찾습니다. ADC, 이중특이성 항체, 표적 치료제 연구를 주도하며 글로벌 R&D 환경에서 성장할 수 있습니다. 전문성과 열정을 갖춘 분들의 많은 지원 바랍니다.

Use your power for purpose.
A world where people with cancer live better and longer lives. That’s Pfizer’s vision. Join us.
Off
Learn More About our R&D Details

Your expertise will be more than just an addition — it will be vital in turning the vast potential of our portfolio into reality.
Explore Open Positions Details
Your joy and well-being come first.

At Pfizer, we’ve structured our compensation policies and practices so colleagues are rewarded based on the contributions they make to our business.

We offer colleagues health and wellness programs that help them maintain and promote health and wellness. Depending on the country, these programs can include:
Health and disability insurance
Preventative health programs
Medical screening
Free or reduced-cost vaccinations
Discounts on Pfizer products
Nutrition and fitness counseling

Depending on local customs and practices, Pfizer offers colleagues several benefits to help them meet their financial goals. These programs can include:
Access to colleague-directed retirement funds
Company contributions to retirement financial vehicles
Life insurance
Financial planning education

We encourage you to grow your skills and explore opportunities at Pfizer. Our colleague-centric approach celebrates you and your strengths to offer the best opportunities so you can realize your full potential. Programs can include:
Dr. Albert Bourla, Pfizer Chairman and Chief Executive Officer
Enabled by the deep technical expertise and scale of the Pfizer network, we’re uniquely positioned to deliver on our vision of accelerating breakthroughs that help people with cancer live better and longer lives.
Learn more about our vision. Details
Antibody-drug conjugates (ADCs) are a type of targeted medicine designed to attach to specific proteins on the surface of cancer cells to deliver cancer-killing medicine directly to tumors. ADCs can also work in the surrounding tumor area and may activate immune cells nearby to help kill cancer cells. The ADC design is intended to reduce damage to healthy cells.
Bispecific medicines are made by combining two different binding arms – one that recognizes cancer cells and one that recognizes specialized immune cells called T-cells. When these two cell types are pulled together by the bispecific medicine, the body’s immune system is activated to destroy the cancer cell.
Pfizer’s targeted therapies include oral medicines that are small enough to easily enter cancer cells and targeted to slow or stop cancer growth. By acting inside of the cancer cell, small-molecule medicines aim to reduce the damage to healthy cells.

This is where you’ll make progress possible. Collaborate, learn, and innovate with first-class talent around the world.